About Inner Cosmos
Inner Cosmos is a company based in Portola Valley (United States) founded in 2017 by Dan Moran. It operates as a HealthTech. Inner Cosmos has raised $11.87 million across 2 funding rounds from investors including lool ventures, KittyHawk Ventures and Loup Funds. Inner Cosmos offers products and services including Digital Pill. Inner Cosmos operates in a competitive market with competitors including Neuralink, Freespira, Motif neurotech, Paradromics and Sooma Oy, among others.
- Headquarter Portola Valley, United States
- Founders Dan Moran
- SectorsHealthcareTechnology
- Website innercosmos.io
- Social LinkedIn
- Total Equity Funding$11.87M (USD)
in 2 rounds
- Latest Funding Round$1.87M (USD), Seed
Nov 2024
- Investorslool ventures
& 2 more
Products & Services of Inner Cosmos
Inner Cosmos offers a comprehensive portfolio of products and services, including Digital Pill.
A minimally invasive device for treating depression effectively.
Funding Insights of Inner Cosmos
Inner Cosmos has successfully raised a total of $11.87M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.87 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.87M
- Total Rounds 2
- Last Round Seed — $1.87M
- First Round $10M
(Mar 2022)
- Investors Count 3
All 2 funding rounds of Inner Cosmos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $1.87M | Seed | – | – | – |
| Mar 2022 | $10M | Seed | – | Lool Ventures |
3 investors in total: 3 institutional.
Investors in Inner Cosmos
Inner Cosmos has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include lool ventures, KittyHawk Ventures and Loup Funds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed funding is offered by lool ventures to startups. | – | lool.vc | Israel | |
- | – | kittyhawk.vc | - | |
Investments in tech-focused companies are made by Loup Funds. | – | loupfunds.com | Minneapolis, United States |
Investor details for Inner Cosmos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Inner Cosmos
17 people are tracked at Inner Cosmos (9 in leadership, 7 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Dan Moran | Co-Founder & VP | Leadership |
Tal Ein-Gar | Head of Technology | Leadership |
Tal Ein-Gar (Garber) | Head of Engineering | Leadership |
Susan Alpert | Consulting Chief Regulatory Officer | Leadership |
Darin Dougherty | Chief Psychiatrist | Leadership |
Eric Leuthardt | Chief Medical Officer & Co-Founder | Leadership |
Meron Gribetz | CEO & Co-Founder | Leadership |
Mandy . | Co-Founder and Chief Science Officer | Leadership |
Yvette Dzumaga | VP Of Investor Relations, Trials, Brand | Leadership |
Siegfried Kasper | Advisor | Board & advisors |
Gil Zalsman | Advisor | Board & advisors |
Wiesław Cubała | Advisor | Board & advisors |
Ed Boyden | Head of Advisory Board & Co-Founder | Board & advisors |
Jeff Apter | Advisor | Board & advisors |
Allan Young | Advisor | Board & advisors |
Madhukar Trivedi | Advisor | Board & advisors |
Andrew Czarnecki | Principal Electrical Engineer | Team |
Complete people profiles for Inner Cosmos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Inner Cosmos
3 dated milestones of Inner Cosmos across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Inner Cosmos is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Seed, of $1.9M.
Competitors of Inner Cosmos
Inner Cosmos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neuralink, Freespira, Motif neurotech, Paradromics and Sooma Oy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neuralink.com | 2016 | San Francisco, United States | $1.29B | 331 | Implantable brain-computer interfaces are developed for thought-based device control. | |
| freespira.com | 2008 | Danville, United States | $48.94M | 25 | Panic disorders are treated via breathing device and mobile app. | |
| motifneuro.tech | 2022 | Houston, United States | $18.75M | – | Minimally invasive bioelectronics are developed for mental health disorders. | |
| paradromics.com | 2015 | Austin, United States | $88.66M | – | Data streaming brain-computer interfaces for neural connections are provided. | |
| soomamedical.com | 2013 | Helsinki, Finland | $6.58M | – | Non-invasive neuromodulation therapies | |
| neuronetics.com | 2001 | Malvern, United States | $177.8M | 167 | Non-invasive magnetic therapies for psychiatric and neurological disorders are developed. | |
| sparkbiomedical.com | 2018 | Houston, United States | $31.23M | 18 | Neurostimulation devices for opioid withdrawal symptoms are developed. | |
| cervel.com | 2008 | Redwood, United States | $23.6M | – | Treatment-resistant depression is addressed through non-invasive transcranial magnetic stimulation. |
Detailed competitors of Inner Cosmos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inner Cosmos
Complete news archive for Inner Cosmos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Inner Cosmos
10 companies that operate in the same segment as Inner Cosmos (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Inner Cosmos
Inner Cosmos was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Inner Cosmos is headquartered in Portola Valley, United States. It is registered at Portola Valley, California, United States.
Inner Cosmos is a funded company, having raised a total of $11.87M across 2 funding rounds to date. The company's 1st funding round was a Seed of $10M, raised on Mar 2022.
Inner Cosmos is engaged in developing innovative neurotechnology solutions for mental health. The company specializes in the Digital Pill, a minimally invasive brain-computer interface designed to treat depression by stimulating brain networks. Operating within the healthcare sector, Inner Cosmos collaborates with academic institutions like Washington University School of Medicine for clinical trials. Their approach eliminates the need for frequent clinic visits, integrating therapy seamlessly into patients lifestyles. Research and early feasibility studies are conducted to ensure safety and efficacy of their solutions.
Inner Cosmos's top competitors include Neuralink, Paradromics and Motif neurotech.
Inner Cosmos offers Digital Pill.
Inner Cosmos has 3 investors. Key investors include lool ventures, KittyHawk Ventures, and Loup Funds.